...
首页> 外文期刊>International Journal of Clinical and Experimental Medicine >Effects of ischemic preconditioning and iloprost on myocardial ischemia-reperfusion damage in rats
【24h】

Effects of ischemic preconditioning and iloprost on myocardial ischemia-reperfusion damage in rats

机译:缺血预处理和伊洛前列素对大鼠心肌缺血再灌注损伤的影响

获取原文

摘要

This study investigates the effects of cardiac ischemic preconditioning and iloprost on reperfusion damage in rats with myocardial ischemia/reperfusion. 38 male Wistar Albino rats used in this study were divided into 5 groups. The control group (Group 1) (n=6), ischemia/reperfusion (IR) group (Group 2) (n=8), cardiac ischemic preconditioning (CIP) group (Group 3) (n=8), iloprost (ILO) group (Group 4) (n=8), and cardiac ischemic preconditioning + iloprost (CIP+ILO) group (Group 5) (n=8). Pre-ischemia, 15 minutes post-ischemia, 45 minutes post-reperfusion, mean blood pressure (MBP), and heart rates (HR) were recorded. The rate-pressure product (RPP) was calculated. Post-reperfusion plasma creatine kinase-MB (CK-MB), lactate dehydrogenase (LDH), troponin (cTn) vlaues, and infarct size/area at risk (IS/AAR) were calculated from myocardial tissue samples. Arrhythmia and ST segment elevations were evaluated during the ischemia and reperfusion stages. Although the MBP, HR, RPP values, biochemical parameters of CK-MB and LDH levels, IS/AAR rates, ST segment elevation values were found to be similar in CIP and CIP+ILO groups and the IR and ILO groups (p>0.05), CIP-containing group values had a positively meaningful difference (p<0.05) compared with the IR and ILO group. While mild-moderate findings of damage were observed in Group 3 and Group 5, severely findings of damage were releaved in Group 2 and Group 4. The arrhythmia score of the ILO group was meaningfully lower (F: 41.4, p<0.001) than the IR group. We can conclude that the effects of myocardial reperfusion damage can be reduced by cardiac ischemic preconditioning, intravenous iloprost reduced the incidence of ventricular arrhythmia associated with reperfusion, and its use with CIP caused no additional changes.
机译:这项研究调查了心脏缺血预处理和伊洛前列素对心肌缺血/再灌注大鼠再灌注损伤的影响。本研究中使用的38只雄性Wistar Albino大鼠分为5组。对照组(第1组)(n = 6),缺血/再灌注(IR)组(第2组)(n = 8),心脏缺血预处理(CIP)组(第3组)(n = 8),伊洛前列素(ILO) )组(第4组)(n = 8),心脏缺血预处理+伊洛前列素(CIP + ILO)组(第5组)(n = 8)。记录缺血前,缺血后15分钟,再灌注后45分钟,平均血压(MBP)和心率(HR)。计算速率-压力乘积(RPP)。从心肌组织样本中计算出再灌注后血浆肌酸激酶-MB(CK-MB),乳酸脱氢酶(LDH),肌钙蛋白(cTn)峰和梗塞面积/危险区域(IS / AAR)。在缺血和再灌注阶段评估心律不齐和ST段抬高。尽管在CIP和CIP + ILO组以及IR和ILO组中发现MBP,HR,RPP值,CK-MB和LDH水平的生化参数,IS / AAR率,ST段抬高值相似(p&#x0003e ; 0.05),与IR和ILO组相比,包含CIP的组值具有积极意义的差异(p< 0.05)。尽管在第3组和第5组中观察到轻度至中度的损害发现,但在第2组和第4组中发现了严重的损害发现。ILO组的心律失常评分显着降低(F:41.4,p< 0.001)比IR组我们可以得出结论,心肌缺血预处理可以减轻心肌再灌注损伤的影响,静脉注射伊洛前列素可以降低与再灌注相关的室性心律失常的发生率,并且与CIP配合使用不会引起其他变化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号